The potential25 Aug 2020 02:54
versus the realism of actual TO offers feel will be a little bit off I fell, unless there are multiple interested parties and an auction. Full disclosure... no where near a beginner never-mind expert on valuations for potential TO, but I just don't see a big Pharma 'over-paying' unless they are beating off others. If and it's still a decently big if there is a TO approach I really don't expect it to be over 10p and would expect a 5-10p range. This still certainly isn't to be sniffed at obviously, but I'm just cautious of the higher numbers being referenced - but again not saying theat they couldn't be achieved if everything aligns also. Anyway, hoping to be in the 1-3p range by year end for a start if news flows. GLA